Dr Gary Franklin Hoffman, MD | |
235 Spur Lane, 202, Ketchum, ID 83340-1529 | |
(208) 725-5522 | |
(208) 725-5522 |
Full Name | Dr Gary Franklin Hoffman |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 235 Spur Lane, Ketchum, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194045252 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | M5780 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gary Franklin Hoffman, MD Po Box 1529, Ketchum, ID 83340-1529 Ph: (208) 725-5522 | Dr Gary Franklin Hoffman, MD 235 Spur Lane, 202, Ketchum, ID 83340-1529 Ph: (208) 725-5522 |
News Archive
Take Care Health Systems, a wholly-owned subsidiary of Walgreens and the nation's largest and most comprehensive manager of convenient care clinics and worksite health and wellness centers, today praised the US Senate for its declaration of August 2-8 as "National Convenient Care Clinic Week". The resolution was introduced by Senator Daniel Inouye (D-HI) and Senator Thad Cochran (R-MS) and passed the Senate by unanimous consent.
Scientists in Italy say they have discovered that the grapes used to make some of the most popular red wines contain high levels of the sleep hormone melatonin.
Warning labels on medications about the dangers of driving are not enough to stop people getting behind the wheel with most driving while affected by drugs, according to Queensland University of Technology road safety researcher Dr Tanya Smyth.
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center, with colleagues in Spain and Germany, have unraveled how elevated levels of particular proteins in cancer cells trigger hyperactivity in other proteins, fueling the growth and spread of a variety of cancers.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
› Verified 6 days ago